Tentang perusahaan
SK Plasma Core Indonesia, part of South Korea’s SK Group, is a biopharmaceutical company specializing in plasma-derived medicines that treat hemophilia, immune deficiencies, and severe bleeding disorders. In partnership with Indonesia’s Ministry of Health, SK Plasma is establishing a plasma fractionation plant in Indonesia to secure local production of life-saving treatments. More than a single project, SK Plasma is committed to building a sustainable presence by transferring expertise, supporting plasma donation programs, and ensuring reliable access to vital medicines made from plasma donated by Indonesians, for Indonesians.